We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.97%
2 Consumer Discretionary 10.47%
3 Healthcare 9.98%
4 Financials 9.67%
5 Industrials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVGW
1451
DELISTED
Calavo Growers
CVGW
$94K ﹤0.01%
1,424
– –
SASR
1452
DELISTED
Sandy Spring Bancorp Inc
SASR
$94K ﹤0.01%
4,070
– –
EPZM
1453
DELISTED
Epizyme, Inc
EPZM
$94K ﹤0.01%
7,880
– –
BKLN icon
1454
Invesco Senior Loan ETF
BKLN
$6.76B
$93K ﹤0.01%
4,293
+1,083
+34% +$23.5K
HLIO icon
1455
Helios Technologies
HLIO
$2.69B
$93K ﹤0.01%
2,542
– –
LRN icon
1456
Stride
LRN
$3.46B
$93K ﹤0.01%
3,520
– –
MDGL icon
1457
Madrigal Pharmaceuticals
MDGL
$11.7B
$93K ﹤0.01%
787
– –
SGMO
1458
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$93K ﹤0.01%
9,803
– –
TNC icon
1459
Tennant Co
TNC
$1.17B
$93K ﹤0.01%
1,548
– –
CMA
1460
DELISTED
Comerica
CMA
$92K ﹤0.01%
2,405
– –
FARO
1461
DELISTED
Faro Technologies
FARO
$92K ﹤0.01%
1,514
– –
NNI icon
1462
Nelnet
NNI
$4.57B
$92K ﹤0.01%
1,533
– –
REG icon
1463
Regency Centers
REG
$14B
$92K ﹤0.01%
2,413
-489
-17% -$20.1K
SHM icon
1464
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
$92K ﹤0.01%
1,856
+601
+48% +$30K
SUPN icon
1465
Supernus Pharmaceuticals
SUPN
$2.81B
$92K ﹤0.01%
4,418
– –
IRT icon
1466
Independence Realty Trust
IRT
$4.01B
$91K ﹤0.01%
7,851
– –
IWD icon
1467
iShares Russell 1000 Value ETF
IWD
$84.2B
$91K ﹤0.01%
773
-474
-38% -$56.2K
MEI icon
1468
Methode Electronics
MEI
$608M
$91K ﹤0.01%
3,192
– –
SAFT icon
1469
Safety Insurance
SAFT
$1.52B
$91K ﹤0.01%
1,323
– –
TRS icon
1470
TriMas Corp
TRS
$1.4B
$91K ﹤0.01%
3,997
– –
HTLF
1471
DELISTED
Heartland Financial USA, Inc.
HTLF
$91K ﹤0.01%
3,037
– –
CERS icon
1472
Cerus
CERS
$601M
$90K ﹤0.01%
14,314
– –
CSW
1473
CSW Industrials
CSW
$5.62B
$90K ﹤0.01%
1,167
-141
-11% -$10.2K
KPTI icon
1474
Karyopharm Therapeutics
KPTI
$45.8M
$90K ﹤0.01%
413
– –
MTRN icon
1475
Materion
MTRN
$5.9B
$90K ﹤0.01%
1,729
– –
57 58
59
60 61

Similar funds

AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.